Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 29, 2017

DrugPatentWatch Database Preview

Hydrocortisone valerate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for hydrocortisone valerate and what is the scope of hydrocortisone valerate patent protection?

Hydrocortisone valerate
is the generic ingredient in two branded drugs marketed by Ranbaxy, Taro, Ranbaxy Labs Ltd, Perrigo New York, Fougera Pharms, and G And W Labs Inc, and is included in seven NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are sixty drug master file entries for hydrocortisone valerate. Eight suppliers are listed for this compound.

Summary for Generic Name: hydrocortisone valerate

Tradenames:2
Patents:1
Applicants:6
NDAs:7
Drug Master File Entries: see list60
Suppliers / Packagers: see list8
Bulk Api Vendors: see list23
Clinical Trials: see list119
Patent Applications: see list3,149
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:hydrocortisone valerate at DailyMed

Pharmacology for Ingredient: hydrocortisone valerate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro
HYDROCORTISONE VALERATE
hydrocortisone valerate
OINTMENT;TOPICAL075043-001Aug 25, 1998RXNoYes► Subscribe► Subscribe
Ranbaxy
WESTCORT
hydrocortisone valerate
OINTMENT;TOPICAL018726-001Aug 8, 1983DISCNYesNo► Subscribe► Subscribe
Perrigo New York
HYDROCORTISONE VALERATE
hydrocortisone valerate
CREAM;TOPICAL075666-001May 24, 2000ABRXNoNo► Subscribe► Subscribe
Ranbaxy Labs Ltd
WESTCORT
hydrocortisone valerate
CREAM;TOPICAL017950-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
Fougera Pharms
HYDROCORTISONE VALERATE
hydrocortisone valerate
OINTMENT;TOPICAL075085-001Jul 31, 2001DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Formulary management
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot